A1c EZ 2.0 GP Glycohemoglobin Analyzer

HbA1c, a product of the non-enzymatic glycation process involving the exposure of hemoglobin to plasma glucose, stands as a poignant reflection of average glycemia spanning an extended temporal domain. It assumes a pivotal role in assessing the efficacy of Diabetes Management and carries substantial prognostic worth concerning diabetes-related complications. Lowering HbA1c levels has demonstrated a notable reduction in the incidence of such complications.

An HbA1c level equal to or surpassing 6.5% (48 mmol/mol) forms part of the diagnostic criteria for diabetes. The normal range for HbA1c falls between 4.0% and 5.7% (20-39 mmol/mol), while values ranging from 5.7% to 6.4% (39-46 mmol/mol) indicate the presence of prediabetes.

The point-of-care HbA1c Test allows for prompt adjustments in treatment, thereby presenting a timely opportunity for interventions. Employing Boronate Affinity Chromatography, the BioHermes A1C EZ 2.0 Glycohemoglobin Analyzer ensures precision of an exceptional caliber with an accuracy of ≤3%. A mere droplet of blood, obtained from either a fingertip or a vein, suffices to yield results within a scant 5 minutes.

In consideration of convenience during transportation and storage, the Glycohemoglobin Test Kit is purposefully designed to be maintained at ambient room temperature. This decision exemplifies BioHermes' commitment to mitigating the environmental impact associated with cold room storage, as well as its contribution to the escalating issue of global warming.